Listener feedback, statin eligibility and Yogi Berra, evidence-based medicine and heterogenous treatment effects, and MRAs in HF are the topics John Mandrola, MD, discusses in this week's podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

https://www.medscape.com/twic

I. Listener Feedback

ASPIRE AF https://classic.clinicaltrials.gov/ct2/show/NCT03968393
Butala paper: Stroke After TAVR With and Without EPD https://www.ahajournals.org/doi/abs/10.1161/CIRCINTERVENTIONS.123.013697
PROTECTED TAVR
Heuts meta-analysis: EPD During TAVR https://heart.bmj.com/content/110/11/757

II. Statin Eligibility

JAMA-IM: Data Analytic Choices and Predicting Vascular Events https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2819821
Zeraatker Specification Analysis Paper https://doi.org/10.1016/j.jclinepi.2024.111278
PCE https://www.mdcalc.com/calc/3398/ascvd-atherosclerotic-cardiovascular-disease-2013-risk-calculator-aha-acc

III. Heterogenous Treatment Effect

Weisberg and Dailey-Higgs
DANISH

IV. Heart Failure and MRAs

RALES https://www.nejm.org/doi/full/10.1056/NEJM199909023411001
EMPHASIS https://www.nejm.org/doi/full/10.1056/NEJMoa1009492
Combined analysis (Matsumoto)

You may also like:

The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

Questions or feedback, please contact news@medscape.net